Prescription

Aging Wellness Spring Expo Celebrates the Review-Journal Live Well Speaker Series and Active Lifestyles at South Point Hotel Casino & Spa

Retrieved on: 
Thursday, February 22, 2024

LAS VEGAS, Feb. 22, 2024 /PRNewswire/ -- Nevada's largest Aging Wellness Expo for active adults 50+ returns for the first seasonal event of the year. The Expo, powered by the Las Vegas Review-Journal and presented by Optum - Nevada, heads to South Point on Saturday, March 2, 2024, from 9 AM. to 3 PM. Access to health, financial, and home improvement companies and countless resources are free for attendees. Early bird arrivals can enjoy coffee and breakfast rolls and, in the afternoon, sample healthy snacks.

Key Points: 
  • The Expo, powered by the Las Vegas Review-Journal and presented by Optum - Nevada, heads to South Point on Saturday, March 2, 2024, from 9 AM.
  • The Medicine on the Move vehicle visits locations throughout the state, providing patients and health plan members easy access to care.
  • Other topics in the Live Well series feature "A Mindset to Live 100 years or More" with long-life Era™ motivational speaker Marla Letizia.
  • Also, follow Aging Wellness on the Review-Journal's Facebook page for news and information on 50+ active lifestyles.

Liberty HealthShare Earns GuideStar Gold Seal

Retrieved on: 
Thursday, February 22, 2024

CANTON, Ohio, Feb. 22, 2024 /PRNewswire/ -- For the third straight year, Liberty HealthShare® has been awarded the GuideStar Gold Seal by Candid, ranking it among the country's best non-profit organizations for transparency and accountability.

Key Points: 
  • CANTON, Ohio, Feb. 22, 2024 /PRNewswire/ -- For the third straight year, Liberty HealthShare® has been awarded the GuideStar Gold Seal by Candid, ranking it among the country's best non-profit organizations for transparency and accountability.
  • Liberty HealthShare has earned a GuideStar Gold Seal, given to the top non-profits for transparency and accountability.
  • Less than two percent of the 1.8 million non-profits included on Candid have earned a Gold Seal.
  • "We are thrilled to once again receive this recognition from Candid," said Dorsey Morrow, Liberty HealthShare chief executive officer.

Rightway Empowers Members to Make Smarter Rx Decisions with Proactive Drug Search

Retrieved on: 
Wednesday, February 21, 2024

Proactive drug search allows members to easily discover the price of any medication in their plan, whether the doctor has already sent in the prescription or not, empowering them to make the most informed decisions about their healthcare spending.

Key Points: 
  • Proactive drug search allows members to easily discover the price of any medication in their plan, whether the doctor has already sent in the prescription or not, empowering them to make the most informed decisions about their healthcare spending.
  • With just a few clicks, Rightway members can access estimated drug prices at their preferred pharmacy and compare prices across the Rightway pharmacy network, including mail-order options and lower-cost therapeutic alternatives.
  • Proactive drug search offers unprecedented transparency and puts the power back in our members' hands."
  • The proactive drug search feature is available to all Rightway members in the mobile and web app, helping drive transparency and cost savings for members and plan sponsors.

New Milestone in AI as One Network Launches AI Assistant for Supply Chain

Retrieved on: 
Wednesday, February 21, 2024

DALLAS, Feb. 21, 2024 /PRNewswire/ -- One Network Enterprises (ONE), the leading global provider of intelligent control towers and the Digital Supply Chain Network™, is pleased to announce the beta release of NEO Assistant™, the world's first supply chain AI assistant.

Key Points: 
  • NEO Assistant™, the world's first supply chain AI assistant, enables better decision making through real-time actionability, adaptive flows, Smart Prescriptions™, and interactive visualizations
    DALLAS, Feb. 21, 2024 /PRNewswire/ -- One Network Enterprises (ONE), the leading global provider of intelligent control towers and the Digital Supply Chain Network™, is pleased to announce the beta release of NEO Assistant™, the world's first supply chain AI assistant.
  • The assistant needs to understand not only the current real-time state of the user's supply chain but also the (possibly unstated) intent of what the user is asking for.
  • NEO Assistant™ is fully aware of the real-time state of the user's supply chain and re-evaluates its assumptions when this state changes.
  • NEO Assistant™ constantly understands problems in the supply chain as they occur and will suggest intelligent and executable Smart Prescriptions™ which can be executed with a single click.

Shining Bright in the Capital: ASES SOLAR 2024 Conference

Retrieved on: 
Friday, February 16, 2024

BOULDER, Colo., Feb. 16, 2024 /PRNewswire/ -- Join the American Solar Energy Society (ASES) at SOLAR 2024: Connecting Technology & Policy , the 53rd Annual National Solar Conference.

Key Points: 
  • BOULDER, Colo., Feb. 16, 2024 /PRNewswire/ -- Join the American Solar Energy Society (ASES) at SOLAR 2024: Connecting Technology & Policy , the 53rd Annual National Solar Conference.
  • Registration is open , and ASES has made a one-time extension of the early bird deadline to February 29, 2024.
  • SOLAR 2024 will act as a powerful call to action, gathering technical experts, policymakers, industry leaders, students, and solar enthusiasts to converge and collaborate to explore innovative solutions that will shape the future of renewable energy.
  • The lineup of speakers reflects a variety of perspectives, experiences, and expertise, showcasing the richness that a diverse community brings to the solar industry.

Found, the Obesity Medicine Association and the Obesity Action Coalition Take Steps to Close the Gap in Obesity Care With Launch of Obesity Medicine Scholarship

Retrieved on: 
Friday, February 16, 2024

The program will help ensure there are more obesity medicine experts to provide care to those in need by offering resources to medical providers interested in becoming American Board of Obesity Medicine (ABOM) certified.

Key Points: 
  • The program will help ensure there are more obesity medicine experts to provide care to those in need by offering resources to medical providers interested in becoming American Board of Obesity Medicine (ABOM) certified.
  • The Obesity Medicine Scholarship program, funded by Found, encourages physicians to become ABOM certified.
  • The Obesity Medicine Scholarship program aims to bridge the gap by removing the financial barrier of taking the exam.
  • "Without proper training in obesity medicine, it's easy to overlook the inequities that perpetuate the problem," said Kristal Hartman OAC Chair.

GoodRx Now Offering 30 Common Heart Health Medications for Under $30

Retrieved on: 
Thursday, February 15, 2024

GoodRx , the leading destination for prescription savings in the U.S., today announced it is offering 30 of the most common heart health medications for under $30 at more than 70,000 pharmacies nationwide.1 Cardiovascular disease is one of the most prominent conditions facing Americans, affecting nearly half of all U.S. adults.

Key Points: 
  • GoodRx , the leading destination for prescription savings in the U.S., today announced it is offering 30 of the most common heart health medications for under $30 at more than 70,000 pharmacies nationwide.1 Cardiovascular disease is one of the most prominent conditions facing Americans, affecting nearly half of all U.S. adults.
  • By helping people afford their prescriptions, GoodRx is improving health outcomes and reducing the overall strain on the healthcare system.
  • GoodRx’s recent report - The GoodRx Effect - estimates that GoodRx has directly contributed to the prevention of at least 140,000 emergency room visits and 110,000 hospitalizations for major adverse cardiovascular events like heart attack and stroke.
  • The following is a sample list of common generic medications used to treat cardiovascular disease that are available for under $30 on GoodRx.

Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024

Retrieved on: 
Thursday, February 15, 2024

LONDON and SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (the “Company”), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease, today reported financial results for the fiscal second quarter ended December 31, 2023.

Key Points: 
  • LONDON and SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (the “Company”), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease, today reported financial results for the fiscal second quarter ended December 31, 2023.
  • The Company plans to issue another announcement following today’s report of financial results regarding the date and time of its conference call and webcast to discuss second quarter financial results and other key events.
  • Total billable volume of 734 tests during the second quarter (representing 69% of all tests in the period, including non-billable study tests).
  • Operating cost reductions commenced during the fiscal second quarter continued with a fiscal third quarter cash burn target approximately 33% less than in the prior quarter and approximately 50% less than in the first quarter of fiscal 2024.

Preserver.me Introduces the World’s First Full-Feature, Privacy Secure, Personal Digital Diary App

Retrieved on: 
Thursday, February 15, 2024

The world’s first full-feature, privacy secure, personal digital diary app was introduced today by Preserver.me.

Key Points: 
  • The world’s first full-feature, privacy secure, personal digital diary app was introduced today by Preserver.me.
  • Of particular importance is that Preserver is fully anonymous and empowers the user to have complete control over their data storage.
  • “The user can then organize this content in any way they choose – by time and date, by subject, and by any other categorization.
  • Whereas other older and more limited diary apps require subscription fees and registration, the Preserver app and all its features are entirely free.

AMLX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Amylyx Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Retrieved on: 
Wednesday, February 14, 2024

), the Amylyx class action lawsuit charges Amylyx and certain of Amylyx’s top current and former executives with violations of the Securities Exchange Act of 1934.

Key Points: 
  • ), the Amylyx class action lawsuit charges Amylyx and certain of Amylyx’s top current and former executives with violations of the Securities Exchange Act of 1934.
  • A lead plaintiff acts on behalf of all other class members in directing the Amylyx class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Amylyx class action lawsuit.
  • An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Amylyx class action lawsuit.